Other
Motor Function
0
Pipeline Programs↗
2
Active Trials↗
2
Companies Involved↗
Motor Function is an early-stage landscape with 0 programs across 2 companies. The most active players are Utrecht Institute for Pharmaceutical Sciences, Ferring.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Completed8 · 67%
Unknown status1 · 8%
Withdrawn1 · 8%
Not yet recruiting1 · 8%
Active, not recruiting1 · 8%
Clinical Trials
Trial Activity
12 trials
The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries
Completed·—·N/A·NCT00115583·200 enrolled
Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System
Completed·National Institute of Neurological Disorders and Stroke (NINDS)·Phase 1·NCT00453505·976 enrolled
Serotonergic Modulation of Motor Function in Subacute and Chronic SCI
Unknown status·—·Phase 1·NCT01788969·42 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)